A Washington State University (WSU) research team has successfully used a mild electric current to take on and beat drug-resistant bacterial infections, a technology that may eventually be used to treat chronic wound infections. The researchers report on their work in the online edition of npj Biofilms and Microbiomes.
Shorter wound healing time, fewer dressing changes and the opportunity for earlier discharge from the hospital. These are some of the benefits of negative pressure wound therapy to treat wound infections in connection with vascular surgery at the groin. The method, which has become increasingly common, is also cost-effective. This is shown in a thesis from Lund University in Sweden in which the method has undergone its first major scientific evaluation in deep perivascular groin infections after vascular surgery.
Good news for the millions of people who suffer from skin wounds that won’t heal. A team of researchers at Ohio State University has brought a potentially transformative solution to the problem by creating a portable adhesive patch that drives a continuous, small electrical current to stimulate healing and reduce the risk of infection.
The American College of Surgeons (ACS) has released a statement on professional attire for surgeons in and out of the operating room (OR). The new ACS guideline for appropriate attire is based on professionalism, common sense, decorum, and the available evidence.
Imbed Biosciences announces it has received clearance from the Food and Drug Administration (FDA) to market its patented wound dressing for human use. The dressing it calls Microlyte Ag is a sheet as thin as Saran Wrap and can conform to the bumps and crevices of a wound, says company CEO Ankit Agarwal.
In Uganda, taking a bath before surgery, closing the door to the operating theater and ensuring surgeons clean their hands properly can be the difference between life and death. A study involving more than 650 surgical patients, showed the rate of infections halved after new measures were introduced. As a result, patients are spending less time in hospital, resulting in cost-savings for both the patient and the hospital.
Some skin wounds, such as diabetic ulcers, are chronic and may never heal; others, such as burn wounds, are often large and difficult to treat, resulting in pain, infection and scarring. Researchers at the University of California, Los Angeles (UCLA), funded by the National Institutes of Health (NIH), have developed a synthetic biomaterial that fills wounds and aids in regeneration of skin cells, which ultimately improves wound healing.
